高级检索
当前位置: 首页 > 详情页

Prognostic analysis for children with hepatoblastoma with lung metastasis: A single-center analysis of 98 cases

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Capital Med Univ, Dept Pediat, Beijing Tongren Hosp, 2 West South Rd, Beijing 100730, Peoples R China
出处:
ISSN:

关键词: hepatoblastoma lung metastasis metastasectomy prognosis

摘要:
Aims To analyze the factors affecting the prognosis of hepatoblastoma (HB) with lung metastasis in children. Methods The HB patients with lung metastases admitted to Beijing Tongren Hospital, Capital Medical University were collected. The clinical data, overall results, and prognostic factors were analyzed. Multivariate analysis was done by the Cox proportional hazards model for patients' prognosis. Results Finally, 98 HB patients (64 boys and 34 girls) with lung metastasis met the inclusion criteria, in which 64 patients had lung metastases at diagnosis (median age, 22.3 months) and 34 patients developed lung metastases while on treatment (median time, 6.5 months). The survival time and 5-year survival rate of patients with standard treatment were significantly longer than that of without standard treatment (P < .001). The survival time and 3-year survival rate had no difference between patients underwent lung metastasectomy and without lung metastasectomy (P = .099), between different diagnosis time of lung metastasis in HB patients (P = .37), between each histology type (P = .313), and different PRETEXT stage (P = .353). While the survival time and 3-year survival rate of patients with lung metastasis alone were significantly longer than that of patients with extrapulmonary involvement (P = .007). Multivariate Cox proportional hazards model revealed that the lung metastasis accompanied with extrapulmonary involvement was a risk factor affecting prognosis (HR = 0.460, 95% CI 0.239-0.888). Conclusions For HB children with lung metastatic, extrapulmonary involvement might be a high-risk factor of prognosis and standardized treatment with lung metastasectomy might prolong the survival time of them.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 4 区 医学
小类 | 4 区 肿瘤学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 肿瘤学
JCR分区:
出版当年[2019]版:
Q4 ONCOLOGY
最新[2023]版:
Q4 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者机构: [1]Capital Med Univ, Dept Pediat, Beijing Tongren Hosp, 2 West South Rd, Beijing 100730, Peoples R China
通讯作者:
通讯机构: [1]Capital Med Univ, Dept Pediat, Beijing Tongren Hosp, 2 West South Rd, Beijing 100730, Peoples R China [*1]Department ofPediatrics, Beijing Tongren Hospital, Capital Medical University,No 2West South Road, Yizhuang Economic and TechnologicalDevelopment Zone,Beijing 100730,P.R. China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:23549 今日访问量:0 总访问量:1282 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)